References

[1] Unadkat A,Subasinghe S,Harvey RJ,Castle DJ, Methamphetamine use in patients presenting to emergency departments and psychiatric inpatient facilities: what are the service implications? Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists. 2018 Nov 1     [PubMed PMID: 30382752]
[2] Bertol E,Di Milia MG,Fioravanti A,Mari F,Palumbo D,Pascali JP,Vaiano F, Proactive drugs in DFSA cases: Toxicological findings in an eight-years study. Forensic science international. 2018 Oct     [PubMed PMID: 30218868]
[3] Callaghan RC,Halliday M,Gatley J,Sykes J,Taylor L,Benny C,Kish SJ, Comparative hazards of acute myocardial infarction among hospitalized patients with methamphetamine- or cocaine-use disorders: A retrospective cohort study. Drug and alcohol dependence. 2018 Jul 1     [PubMed PMID: 29793190]
[4] Dhein S,Schmelmer K,Guenther J,Salameh A, Aspects of Methamphetamine Abuse in Adolescents and Young Adults in a Thuringian County. European addiction research. 2018     [PubMed PMID: 29902793]
[5] Ma J,Li XD,Wang TY,Li SX,Meng SQ,Blow FC,Ilgen M,Degenhardt L,Lappin J,Wu P,Shi J,Bao YP,Lu L, Relationship between the duration of methamphetamine use and psychotic symptoms: A two-year prospective cohort study. Drug and alcohol dependence. 2018 Jun 1     [PubMed PMID: 29715654]
[6] Dolan SB,Chen Z,Huang R,Gatch MB,     [PubMed PMID: 29378213]
[7] Härtel-Petri R,Krampe-Scheidler A,Braunwarth WD,Havemann-Reinecke U,Jeschke P,Looser W,Mühlig S,Schäfer I,Scherbaum N,Bothe L,Schaefer C,Hamdorf W, Evidence-Based Guidelines for the Pharmacologic Management of Methamphetamine Dependence, Relapse Prevention, Chronic Methamphetamine-Related, and Comorbid Psychiatric Disorders in Post-Acute Settings. Pharmacopsychiatry. 2017 May     [PubMed PMID: 28445899]
[8] Wodarz N,Krampe-Scheidler A,Christ M,Fleischmann H,Looser W,Schoett K,Vilsmeier F,Bothe L,Schaefer C,Gouzoulis-Mayfrank E, Evidence-Based Guidelines for the Pharmacological Management of Acute Methamphetamine-Related Disorders and Toxicity. Pharmacopsychiatry. 2017 May     [PubMed PMID: 28297728]
[9] Bhatt M,Zielinski L,Baker-Beal L,Bhatnagar N,Mouravska N,Laplante P,Worster A,Thabane L,Samaan Z, Efficacy and safety of psychostimulants for amphetamine and methamphetamine use disorders: a systematic review and meta-analysis. Systematic reviews. 2016 Nov 14     [PubMed PMID: 27842569]
[10] Jones R,Woods C,Usher K, Rates and features of methamphetamine-related presentations to emergency departments: An integrative literature review. Journal of clinical nursing. 2018 Jul     [PubMed PMID: 29679414]
[11] Wang L,Min JE,Krebs E,Evans E,Huang D,Liu L,Hser YI,Nosyk B, Polydrug use and its association with drug treatment outcomes among primary heroin, methamphetamine, and cocaine users. The International journal on drug policy. 2017 Nov     [PubMed PMID: 28888099]